Ansbert Gadicke, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 121,157 shares at $27.50 ($3.4M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $3.4M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 30,018 | $825K | 24.6% |
| 2 | $27.99 | 6,063 | $170K | 5.0% |
| 3 | $27.99 | 6,063 | $170K | 5.0% |
| 4 | $27.79 | 38,677 | $1.1M | 32.0% |
| 5 | $27.79 | 38,677 | $1.1M | 32.0% |
| 6 | $28.15 | 1,659 |
| $47K |
| 1.4% |
| Total | $27.74 avg | 121,157 | $3.4M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |